Ajanta Pharma Closes Trading Window for Insider Trading

Ajanta Pharma Ltd has announced the closure of its trading window for dealing in the company's securities. This closure is in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. The trading window will be shut from Wednesday, July 1, 2026, and will reopen 48 hours after the declaration of the financial results for the quarter ending June 30, 2026. This measure is standard practice to prevent potential insider trading during periods when material non-public information may be available.